Normal-appearing grey and white matter T1 abnormality in early relapsing-remitting multiple sclerosis:: a longitudinal study

被引:37
作者
Davies, G. R. [1 ]
Hadjiprocopis, A. [1 ]
Altmann, D. R. [1 ]
Chard, D. T. [1 ]
Griffin, C. M. [1 ]
Rashid, W. [1 ]
Parker, G. J. [1 ]
Tofts, P. S. [1 ]
Kapoor, R. [1 ]
Thompson, A. J. [1 ]
Miller, D. H. [1 ]
机构
[1] UCL, NMR Res Unit, Inst Neurol, London WC1N 3BG, England
关键词
early MS; grey matter; longitudinal; multiple sclerosis; normal-appearing white matter; T1 relaxation time; MAGNETIZATION-TRANSFER RATIO; T1; RELAXATION-TIMES; METABOLITE CHANGES; QUANTITATIVE MRI; BRAIN-TISSUE; RESONANCE; LESION; DISABILITY; HISTOGRAMS; INCREASE;
D O I
10.1177/1352458506070726
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective To investigate the presence and evolution of T-1 relaxation time abnormalities in normal-appearing white matter (NAWM) and grey matter (GM), early in the course of relapsing-remitting multiple sclerosis (MS). Methods Twenty-three patients with early relapsing-remitting MS and 14 healthy controls were imaged six monthly for up to three years. Mean follow-up was 26 months for MS patients and 24 months for controls. Dual-echo fast-spin echo and gradient-echo proton-density and T-1-weighted data sets (permitting the calculation of a T-1 map) were acquired in all subjects. GM and NAWM T-1 histograms were produced and a hierarchical regression model was used to investigate changes in T-1 over time. Results At baseline, significant patient-control differences were seen, both in NAWM (P<0.001) and in GM (P=0.01). At follow-up, there was no evidence for a serial change in either mean T-1 or peak-location for either NAWM or GM. There was weak evidence for a decline in patient NAWM peak-height and also evidence for a decline in control GM peak-height. Conclusion There are significant and persistent abnormalities of NAWM and GM T-1 in early relapsing-remitting MS. Further studies should address whether such T-1 measures have a role in prognosis or therapeutic monitoring.
引用
收藏
页码:169 / 177
页数:9
相关论文
共 46 条
[1]   HISTOLOGICAL, HISTOCHEMICAL AND BIOCHEMICAL-STUDY OF THE MACROSCOPICALLY NORMAL WHITE MATTER IN MULTIPLE-SCLEROSIS [J].
ALLEN, IV ;
MCKEOWN, SR .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1979, 41 (01) :81-91
[2]   Multimodal image coregistration and partitioning - A unified framework [J].
Ashburner, J ;
Friston, K .
NEUROIMAGE, 1997, 6 (03) :209-217
[3]   Voxel-based morphometry - The methods [J].
Ashburner, J ;
Friston, KJ .
NEUROIMAGE, 2000, 11 (06) :805-821
[4]   MAGNETIC-RESONANCE RELAXATION-TIME MAPPING IN MULTIPLE-SCLEROSIS - NORMAL APPEARING WHITE-MATTER AND THE INVISIBLE LESION LOAD [J].
BARBOSA, S ;
BLUMHARDT, LD ;
ROBERTS, N ;
LOCK, T ;
EDWARDS, RHT .
MAGNETIC RESONANCE IMAGING, 1994, 12 (01) :33-42
[5]   THE LONGSTANDING MS LESION - A QUANTITATIVE MRI AND ELECTRON-MICROSCOPIC STUDY [J].
BARNES, D ;
MUNRO, PMG ;
YOUL, BD ;
PRINEAS, JW ;
MCDONALD, WI .
BRAIN, 1991, 114 :1271-1280
[6]   THE CHARACTERIZATION OF EXPERIMENTAL GLIOSIS BY QUANTITATIVE NUCLEAR MAGNETIC-RESONANCE IMAGING [J].
BARNES, D ;
MCDONALD, WI ;
LANDON, DN ;
JOHNSON, G .
BRAIN, 1988, 111 :83-94
[7]   A longitudinal study of abnormalities on MRI and disability from multiple sclerosis [J].
Brex, PA ;
Ciccarelli, O ;
O'Riordan, JI ;
Sailer, M ;
Thompson, AJ ;
Miller, DH .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (03) :158-164
[8]   Lesion heterogeneity in multiple sclerosis: a study of the relations between appearances on T1 weighted images, T1 relaxation times, and metabolite concentrations [J].
Brex, PA ;
Parker, GJM ;
Leary, SM ;
Molyneux, PD ;
Barker, GJ ;
Davie, CA ;
Thompson, AJ ;
Miller, DH .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2000, 68 (05) :627-632
[9]   Progressive grey matter atrophy in clinically early relapsing-remitting multiple sclerosis [J].
Chard, DT ;
Griffin, CM ;
Rashid, W ;
Davies, GR ;
Altmann, DR ;
Kapoor, R ;
Barker, GJ ;
Thompson, AJ ;
Miller, DH .
MULTIPLE SCLEROSIS JOURNAL, 2004, 10 (04) :387-391
[10]   Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis [J].
Chard, DT ;
Griffin, CM ;
McLean, MA ;
Kapeller, P ;
Kapoor, R ;
Thompson, AJ ;
Miller, DH .
BRAIN, 2002, 125 :2342-2352